Enrollment open in phase III study of fostamatinib in warm antibody autoimmune hemolytic anemia May 17, 2019
Bayer, Dana-Farber Cancer Institute and The Broad Institute patent mutant EGFR inhibitors May 17, 2019
European Commission approves Revlimid and Imnovid-based triplet regimens for multiple myeloma May 17, 2019
RSS